Jeremiah A. Johnson, ph.d. assistant professor, department of chemistry, massachusetts institute of technology key research interests The johnson laboratory seeks creative, macromolecular solutions to problems at the interface of chemistry, medicine, biology, and materials science. Novel, nanoscopic branched-arm star polymer architectures for in vivo drug/gene delivery and supported catalysis. Johnson’s Group Welcome to the website: http://web.mit.edu/johnsongroup/

Medicilon is one of the professional preclinical CRO in china, which provides one-stop integrated services including biology, chemistry and preclinical. Medicilon offers fully integrated pharmaceutical services for the global scientific community. They focus on providing an exceptional client-centered experience and advancing the drug discovery process. At medicilon, you could find the professional, the effective and the comprehensive solutions. Welcome to the website: http://www.medicilon.com/

SINOPEG signed a non-exclusive Licensing and Commercialization Agreement with QuiaPEG Pharmaceutical Holding AB in 2018 for the manufacturing, marketing and sales of products and services based on QuiaPEG´s proprietary Uni-Qleaver® technology. QuiaPEG is headquartered in Uppsala, Sweden, who develops proprietary, releasable PEGylation technologies (Uni-Qleaver®）for the development of prodrugs and biobetters with improved pharmacological properties, e.g. extended half-life and increased tolerability. Welcome to the website:http://www.quiapeg.com/

Fagenbio founded in March 2000, it is located in High-tech Distric Chongqing, China. As a high-tech biopharmaceutical limited company, the company is mainly engaged in recombinant protein research and development of innovative drugs. Fagenbio has a strong R&D team of more than 30 research staff which has rich professional knowledge and experience. Since Fagenbio was established, 12 recombinant protein drugs have been developed, project sponsor and partners include many famous.

About BLAFAR Limited. Blafar Ltd., a biotechnology company spun out from vornia ltd., is committed to produce functionalised biopolymer products for cosmetic and medical devices industry around the world. blafar is focused on designing and manufacturing innovative raw materials for advanced functionalised biopolymers for better outcomes in biomedical applications. blafar provides design, development, and manufacturing service for customised biomaterials. Blafar manufactures biopolymers and bio-inks including functionalised hyaluronic acid, chondroitin sulfate, gelatin, and collagen and their derivatives for biomedical applications. blafar also supplies well defined small molecule drugs or active pharmaceutical ingredient for biological and biomedical use. blafar supplies unique peg-based hyperbranched polymers with customised molecular weights through biocompatible synthesis approaches. Welcome to the website：http://blafar.com/